Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-02-07
2006-02-07
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S252100, C544S091000, C544S403000
Reexamination Certificate
active
06995144
ABSTRACT:
The present invention provides compounds represented by the following formula:wherein X1, X2, X3and X4each independently represents a single bond, C1-6alkylene, etc.; A2represents optionally substituted phenyl, etc.; A1represents an optionally substituted 5- to 7-membered heterocyclic group containing —C(═Q1)—, Q1wherein represents oxygen, sulfur or ═N—R11, wherein R11represents hydrogen or C1-6alkyl etc.; and Z1represents piperidin-diyl, ect, salts thereof and hydrates of the foregoing.
REFERENCES:
patent: 0 378 255 (1990-07-01), None
patent: 04-054181 (1992-02-01), None
patent: WO 01/53288 (2001-07-01), None
The Merck Manual 16thed., Merck & Co., Inc. Rahway, NJ © 1992, pp. 1110, 1111 and 1518-1524.
Principles of Ambulatory Medicine, 4thed., edited by Barker, Burton and Zieve. © 1995 Williams & Wilkins. pp. 367-371.
Hawley's Condensed Chemical Dictionary, 12th ed., Richard J. Lewis, Sr. , © 1993 by Van Nostrand Reinhold. p. 594.
Concise Encyclopedia Chemistry, edited by Drs. Hans-Dieter Jakubke and Hans Jeschkeit, © 1993 by Walter de Gruyter & Co p. 490.
McGraw-Hill Dictionary of Chemical Terms, 3rd ed. edited by Sybil P. Parker, © 1984 McGraw-Hill, Inc., p. 200.
Charles P. Taylor, et al., Na+channels as targets for neuroprotective drags, Trends in Pharmacological Sciences 16 (1995) pp. 309-316.
Wade S. Kingerya.b.-.A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes, International Association for the Study of Pain 73(1997) 123-139.
E. Kalsoa, et al., Systemic local-anaesthetic-type drugs in chronic pain: a systematic review. European Journal of Pain (1998) 2: 3-14.
Masaki Sakurai*, et al. Positive symptoms in multiple sclerosis: their treatment with sodium channel blockers, lidocaine and mexiletine, Journal of the Neurological Sciences 162 (1999) 162-168.
S ren H. Sindrupa*et al., Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action, International Association for the Study of Pain 83 (1999) 389-400.
Patrick Kwan, et al., The mechanisms of action of commonly used antiepileptic drugs, Pharmacology & Therapeutics 90 (2001) 21-34.
M. Nieto-Barreraa, et al., A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy, Epilepsy Research 46 (2001) 145-155.
Keri Wellington, et al., Oxcarbazepine An Update of its Efficacy in the Management of Epilepsy, CNS Drugs 2001: 15(2): 137-163.
J.M. Stutzmann, et al., 31stAnnual Meeting of Society of Neuroscience 27 (2001) Abstract 199.16.
Gabriela V. Obrocea, et al., Clinical Predictors of Response to Lamotrigine and Gabapentin Monotherapy in Refractory Affective Disorders, Biological Psychiatry 51 (2002) 21-34.
M.K. Atikeler, et al., Optimum usage of prilocaine-lidocaine cream in prematrue ejaculation, Andrologia 34 (2002) 356-359.
Kawano Koki
Kobayashi Kiyoaki
Minami Hiroe
Norimine Yoshihiko
Ono Mutsuko
Choate Hall & Stewart LLP
Eisai Co. Ltd.
Robidoux Andrea L. C.
Tucker Zachary C.
Wilson James O.
LandOfFree
Nitrogen containing heterocyclic compounds and medicines... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nitrogen containing heterocyclic compounds and medicines..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitrogen containing heterocyclic compounds and medicines... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3669141